Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α

Documenti analoghi

• Bu-Shen-Ning-Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4(+) T lymphocytes of ovariectomized mice
  di: Zhang, Jia-Li, et al.
  Pubblicazione: (2018)
• Bu-Shen-Ning-Xin Decoction ameliorated the osteoporotic phenotype of ovariectomized mice without affecting the serum estrogen concentration or uterus
  di: Wang, Ling, et al.
  Pubblicazione: (2015)
• IL-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of NFATc1 and suppressing proximal RANK signaling
  di: Kalliolias, George D., et al.
  Pubblicazione: (2010)
• Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
  di: Song, Min-Kyoung, et al.
  Pubblicazione: (2015)
• Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity
  di: Liu, Yuhao, et al.
  Pubblicazione: (2020)